vs
雅培（ABT）与908 Devices Inc.（MASS）财务数据对比。点击上方公司名可切换其他公司
雅培的季度营收约是908 Devices Inc.的659.3倍（$11.5B vs $17.4M）。908 Devices Inc.净利率更高（24.0% vs 15.5%，领先8.5%）。908 Devices Inc.同比增速更快（21.2% vs 4.4%）。雅培自由现金流更多（$2.6B vs $1.3M）。过去两年908 Devices Inc.的营收复合增速更高（53.0% vs 7.2%）
雅培是总部位于美国伊利诺伊州雅培园的跨国医疗健康企业，业务覆盖美国境外市场药品销售、诊断产品、营养产品及医疗器械等板块，在全球医疗健康领域拥有较高的行业知名度与广泛的市场覆盖。
908 Devices Inc.是一家专注于研发、生产高性能便携式质谱分析设备及相关解决方案的科技企业，产品覆盖生命科学研究、生物制药制造、公共安全、法医鉴定、工业过程监测等领域，服务全球科研机构、制药企业及政府部门客户。
ABT vs MASS — 直观对比
营收规模更大
ABT
是对方的659.3倍
$17.4M
营收增速更快
MASS
高出16.8%
4.4%
净利率更高
MASS
高出8.5%
15.5%
自由现金流更多
ABT
多$2.6B
$1.3M
两年增速更快
MASS
近两年复合增速
7.2%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $11.5B | $17.4M |
| 净利润 | $1.8B | $4.2M |
| 毛利率 | 57.0% | 52.7% |
| 营业利润率 | 19.6% | 17.8% |
| 净利率 | 15.5% | 24.0% |
| 营收同比 | 4.4% | 21.2% |
| 净利润同比 | -80.8% | 121.5% |
| 每股收益（稀释后） | $1.01 | $0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABTMASS
| Q4 25 | $11.5B | $17.4M | ||
| Q3 25 | $11.4B | $14.0M | ||
| Q2 25 | $11.1B | $13.0M | ||
| Q1 25 | $10.4B | $11.8M | ||
| Q4 24 | $11.0B | $14.3M | ||
| Q3 24 | $10.6B | $14.5M | ||
| Q2 24 | $10.4B | $11.5M | ||
| Q1 24 | $10.0B | $7.4M |
净利润ABTMASS
| Q4 25 | $1.8B | $4.2M | ||
| Q3 25 | $1.6B | $-15.0M | ||
| Q2 25 | $1.8B | $-13.3M | ||
| Q1 25 | $1.3B | $43.6M | ||
| Q4 24 | $9.2B | $-19.4M | ||
| Q3 24 | $1.6B | $-29.3M | ||
| Q2 24 | $1.3B | $-12.5M | ||
| Q1 24 | $1.2B | $-10.9M |
毛利率ABTMASS
| Q4 25 | 57.0% | 52.7% | ||
| Q3 25 | 55.4% | 52.5% | ||
| Q2 25 | 56.4% | 48.9% | ||
| Q1 25 | 56.9% | 47.0% | ||
| Q4 24 | 55.0% | 46.5% | ||
| Q3 24 | 55.8% | 53.6% | ||
| Q2 24 | 55.6% | 53.8% | ||
| Q1 24 | 55.2% | 52.4% |
营业利润率ABTMASS
| Q4 25 | 19.6% | 17.8% | ||
| Q3 25 | 18.1% | -116.6% | ||
| Q2 25 | 18.4% | -116.3% | ||
| Q1 25 | 16.3% | -93.6% | ||
| Q4 24 | 17.4% | -116.8% | ||
| Q3 24 | 17.5% | -168.7% | ||
| Q2 24 | 16.1% | -74.5% | ||
| Q1 24 | 13.9% | -102.5% |
净利率ABTMASS
| Q4 25 | 15.5% | 24.0% | ||
| Q3 25 | 14.5% | -107.0% | ||
| Q2 25 | 16.0% | -102.1% | ||
| Q1 25 | 12.8% | 370.2% | ||
| Q4 24 | 84.1% | -135.6% | ||
| Q3 24 | 15.5% | -201.8% | ||
| Q2 24 | 12.5% | -109.5% | ||
| Q1 24 | 12.3% | -147.1% |
每股收益（稀释后）ABTMASS
| Q4 25 | $1.01 | $0.09 | ||
| Q3 25 | $0.94 | $-0.41 | ||
| Q2 25 | $1.01 | $-0.37 | ||
| Q1 25 | $0.76 | $1.23 | ||
| Q4 24 | $5.26 | $-0.58 | ||
| Q3 24 | $0.94 | $-0.84 | ||
| Q2 24 | $0.74 | $-0.37 | ||
| Q1 24 | $0.70 | $-0.33 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.9B | $113.0M |
| 总债务越低越好 | $12.9B | — |
| 股东权益账面价值 | $52.1B | $143.7M |
| 总资产 | $86.7B | $190.1M |
| 负债/权益比越低杠杆越低 | 0.25× | — |
8季度趋势，按日历期对齐
现金及短期投资ABTMASS
| Q4 25 | $8.9B | $113.0M | ||
| Q3 25 | $7.7B | $112.1M | ||
| Q2 25 | $7.3B | $118.6M | ||
| Q1 25 | $6.8B | $124.3M | ||
| Q4 24 | $8.0B | $69.6M | ||
| Q3 24 | $7.8B | $71.7M | ||
| Q2 24 | $7.2B | $77.4M | ||
| Q1 24 | $6.7B | $134.2M |
总债务ABTMASS
| Q4 25 | $12.9B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $14.1B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ABTMASS
| Q4 25 | $52.1B | $143.7M | ||
| Q3 25 | $51.0B | $136.3M | ||
| Q2 25 | $50.6B | $148.8M | ||
| Q1 25 | $48.8B | $159.4M | ||
| Q4 24 | $47.7B | $114.6M | ||
| Q3 24 | $39.8B | $131.0M | ||
| Q2 24 | $39.3B | $156.4M | ||
| Q1 24 | $38.8B | $156.9M |
总资产ABTMASS
| Q4 25 | $86.7B | $190.1M | ||
| Q3 25 | $84.2B | $190.9M | ||
| Q2 25 | $84.0B | $191.7M | ||
| Q1 25 | $81.4B | $196.0M | ||
| Q4 24 | $81.4B | $159.5M | ||
| Q3 24 | $74.4B | $178.3M | ||
| Q2 24 | $73.0B | $208.8M | ||
| Q1 24 | $72.5B | $189.8M |
负债/权益比ABTMASS
| Q4 25 | 0.25× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.30× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.3B | $1.3M |
| 自由现金流经营现金流 - 资本支出 | $2.6B | $1.3M |
| 自由现金流率自由现金流/营收 | 22.9% | 7.6% |
| 资本支出强度资本支出/营收 | 6.0% | 0.0% |
| 现金转化率经营现金流/净利润 | 1.87× | 0.32× |
| 过去12个月自由现金流最近4个季度 | $7.4B | $-24.7M |
8季度趋势，按日历期对齐
经营现金流ABTMASS
| Q4 25 | $3.3B | $1.3M | ||
| Q3 25 | $2.8B | $-4.2M | ||
| Q2 25 | $2.0B | $-5.8M | ||
| Q1 25 | $1.4B | $-15.0M | ||
| Q4 24 | $2.9B | $-2.2M | ||
| Q3 24 | $2.7B | $-5.6M | ||
| Q2 24 | $2.0B | $-13.0M | ||
| Q1 24 | $1.0B | $-9.4M |
自由现金流ABTMASS
| Q4 25 | $2.6B | $1.3M | ||
| Q3 25 | $2.3B | $-4.9M | ||
| Q2 25 | $1.5B | $-5.9M | ||
| Q1 25 | $933.0M | $-15.2M | ||
| Q4 24 | $2.1B | $-2.4M | ||
| Q3 24 | $2.1B | $-5.8M | ||
| Q2 24 | $1.4B | $-13.7M | ||
| Q1 24 | $627.0M | $-10.3M |
自由现金流率ABTMASS
| Q4 25 | 22.9% | 7.6% | ||
| Q3 25 | 20.2% | -34.9% | ||
| Q2 25 | 13.9% | -45.3% | ||
| Q1 25 | 9.0% | -128.9% | ||
| Q4 24 | 19.6% | -17.0% | ||
| Q3 24 | 20.2% | -39.7% | ||
| Q2 24 | 13.8% | -119.4% | ||
| Q1 24 | 6.3% | -138.2% |
资本支出强度ABTMASS
| Q4 25 | 6.0% | 0.0% | ||
| Q3 25 | 4.4% | 4.9% | ||
| Q2 25 | 4.5% | 0.9% | ||
| Q1 25 | 4.7% | 1.4% | ||
| Q4 24 | 6.6% | 1.3% | ||
| Q3 24 | 5.2% | 1.1% | ||
| Q2 24 | 5.1% | 5.6% | ||
| Q1 24 | 4.0% | 12.2% |
现金转化率ABTMASS
| Q4 25 | 1.87× | 0.32× | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.15× | — | ||
| Q1 25 | 1.07× | -0.34× | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 1.64× | — | ||
| Q2 24 | 1.51× | — | ||
| Q1 24 | 0.84× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABT
暂无分部数据
MASS
| Products | $14.3M | 82% |
| Services | $3.0M | 18% |
